Numbness in Side of Face and Forehead
Facial and forehead numbness most likely represents trigeminal neuropathy affecting the ophthalmic (V1) division, and you must obtain MRI imaging of the entire trigeminal nerve pathway from brainstem to peripheral branches to identify potentially life-threatening causes including malignancy, stroke, or demyelinating disease.
Primary Diagnostic Consideration
The lateral face and forehead are innervated by the ophthalmic division (V1) of the trigeminal nerve (CN V), which provides general sensation to this region 1. When a patient presents with numbness in this distribution, you are dealing with trigeminal neuropathy until proven otherwise.
Critical Point About Numbness
Facial numbness—especially if progressive—may be the earliest sign of malignancy or serious pathology, even appearing years before other symptoms 2. This is not a symptom to dismiss or observe without investigation.
Immediate Imaging Workup
MRI with and without contrast covering the entire trigeminal nerve course is the mandatory initial imaging study 1. This must include:
- Brainstem (where the trigeminal nuclei reside)
- Cisternal segment (where the nerve exits the pons)
- Meckel cave and cavernous sinus
- Skull base foramina (superior orbital fissure for V1)
- Orbital and facial soft tissues
The imaging protocol should use thin-cut high-resolution techniques with pre- and post-contrast sequences 1.
Life-Threatening Causes to Rule Out
Brainstem Pathology
The trigeminal nerve can be affected by 1:
- Multiple sclerosis (demyelinating plaques)
- Stroke (infarction or hemorrhage)
- Vascular lesions (compressing vascular loops, aneurysms, vertebrobasilar dolichoectasia)
- Tumors (gliomas, lymphomas, metastases)
- Inflammatory/infectious conditions (meningitis, encephalitis, sarcoidosis)
Peripheral Nerve Pathology
Along the nerve's peripheral course 1:
- Perineural tumor spread (especially squamous cell carcinoma, which can infiltrate the infraorbital nerve)
- Primary tumors affecting the orbit, skull base, or masticator space
- Metastatic disease (particularly from breast cancer, lymphoproliferative disorders, or prostate cancer) 3
Special Consideration: Malignancy
Squamous cell carcinoma and other malignancies can present with isolated facial numbness before any visible lesion appears 4, 5. The "numb cheek" syndrome specifically warns of neoplastic infiltration of the infraorbital nerve 4, 5.
Anatomic Localization
The forehead involvement specifically implicates the supraorbital and supratrochlear branches of V1. If numbness extends to:
- Lateral upper eyelid and external canthus: Consider lacrimal nerve involvement 6
- Cheek and upper lip: Suggests infraorbital nerve (V2) involvement 4, 5
- Lower lip and chin: Indicates mental nerve (V3) involvement, raising concern for mandibular or skull base pathology 5, 3
Uncommon but Important Cause
Cervical radiculopathy (C5-C7) can rarely cause trigeminal neuropathy symptoms 7. While the spinal trigeminal tract extends to C2-C4 levels 1, there are documented cases where lower cervical disk herniation caused facial numbness that resolved with anterior cervical decompression and fusion 7. Consider this if MRI of the trigeminal pathway is unrevealing and the patient has concurrent neck symptoms.
Clinical Pitfalls to Avoid
Do not assume benign etiology without imaging: Progressive numbness demands investigation even if pain is absent 2
Do not order CT as initial imaging: CT is complementary for osseous evaluation but insufficient to evaluate the full trigeminal nerve course 1. Standard CT head coverage cannot assess the peripheral nerve divisions adequately 1
Do not delay imaging: Malignancy may be occult for years, but early detection through imaging when numbness first appears is critical 2
Distinguish from trigeminal neuralgia: Trigeminal neuralgia typically presents with pain (often lancinating) rather than isolated numbness, though both can coexist 1
Follow-Up Strategy
If initial MRI is negative, periodic re-evaluation is mandatory 2. Malignancy or autoimmune disease may not be detectable initially but can declare itself months to years later. The patient requires:
- Clinical reassessment every 3-6 months
- Repeat imaging if symptoms progress
- Laboratory evaluation for autoimmune connective tissue disease if clinically indicated 2